Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Confined Spaces | 1 | 2020 | 10 | 0.720 |
Why?
|
Lymphatic Metastasis | 5 | 2021 | 2915 | 0.620 |
Why?
|
Hematopoietic Stem Cells | 4 | 2022 | 3397 | 0.510 |
Why?
|
Longevity | 1 | 2022 | 1065 | 0.460 |
Why?
|
Mutation | 7 | 2024 | 30053 | 0.390 |
Why?
|
Lymph Nodes | 3 | 2021 | 3465 | 0.360 |
Why?
|
Genetic Heterogeneity | 3 | 2020 | 732 | 0.350 |
Why?
|
Hematopoiesis | 5 | 2022 | 2050 | 0.350 |
Why?
|
Telomerase | 1 | 2015 | 745 | 0.350 |
Why?
|
Neoplasm Metastasis | 3 | 2020 | 4915 | 0.330 |
Why?
|
Colorectal Neoplasms | 3 | 2020 | 6938 | 0.330 |
Why?
|
Cell Proliferation | 9 | 2024 | 10451 | 0.320 |
Why?
|
Phylogeny | 4 | 2020 | 2811 | 0.320 |
Why?
|
Poly G | 2 | 2021 | 7 | 0.320 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1745 | 0.310 |
Why?
|
Atherosclerosis | 3 | 2021 | 3407 | 0.310 |
Why?
|
Aneuploidy | 2 | 2024 | 552 | 0.290 |
Why?
|
Colonic Neoplasms | 2 | 2023 | 2539 | 0.290 |
Why?
|
Macrophages | 5 | 2023 | 5767 | 0.280 |
Why?
|
Breast Neoplasms | 10 | 2024 | 21019 | 0.260 |
Why?
|
Myeloid Cells | 3 | 2021 | 823 | 0.260 |
Why?
|
Neoplasms | 7 | 2024 | 22173 | 0.240 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5790 | 0.230 |
Why?
|
Models, Biological | 5 | 2021 | 9469 | 0.210 |
Why?
|
Microsatellite Repeats | 2 | 2015 | 784 | 0.200 |
Why?
|
Myelopoiesis | 2 | 2020 | 134 | 0.190 |
Why?
|
Osteopontin | 1 | 2023 | 301 | 0.190 |
Why?
|
Germ Layers | 1 | 2021 | 72 | 0.190 |
Why?
|
Mosaicism | 1 | 2024 | 475 | 0.190 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2024 | 592 | 0.180 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3878 | 0.180 |
Why?
|
Guanine | 1 | 2021 | 279 | 0.170 |
Why?
|
Neoplasm Seeding | 1 | 2020 | 85 | 0.170 |
Why?
|
Acetylcholine | 1 | 2022 | 629 | 0.170 |
Why?
|
Biomass | 1 | 2020 | 137 | 0.170 |
Why?
|
Mice | 23 | 2023 | 81539 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 546 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 5314 | 0.150 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3612 | 0.150 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2020 | 507 | 0.150 |
Why?
|
Osteosarcoma | 1 | 2023 | 897 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2020 | 8554 | 0.140 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13381 | 0.140 |
Why?
|
Lymphatic Vessels | 1 | 2021 | 358 | 0.140 |
Why?
|
Animals | 25 | 2023 | 168475 | 0.140 |
Why?
|
Angiotensins | 1 | 2017 | 143 | 0.140 |
Why?
|
INDEL Mutation | 1 | 2017 | 266 | 0.130 |
Why?
|
Receptor, erbB-3 | 1 | 2017 | 143 | 0.130 |
Why?
|
Physical Conditioning, Animal | 1 | 2019 | 365 | 0.130 |
Why?
|
DNA | 2 | 2021 | 7213 | 0.130 |
Why?
|
Diastole | 1 | 2018 | 782 | 0.120 |
Why?
|
Apolipoproteins E | 1 | 2021 | 1443 | 0.120 |
Why?
|
Maytansine | 1 | 2015 | 86 | 0.120 |
Why?
|
Genetic Variation | 2 | 2020 | 6567 | 0.120 |
Why?
|
Embryonic Stem Cells | 1 | 2021 | 1263 | 0.120 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 9420 | 0.110 |
Why?
|
Receptors, CCR2 | 1 | 2015 | 215 | 0.110 |
Why?
|
Sleep Deprivation | 1 | 2021 | 846 | 0.110 |
Why?
|
Immunotherapy | 2 | 2020 | 4652 | 0.110 |
Why?
|
Humans | 33 | 2024 | 761596 | 0.110 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 22174 | 0.110 |
Why?
|
Cell Differentiation | 3 | 2021 | 11530 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1787 | 0.100 |
Why?
|
Brain Neoplasms | 3 | 2021 | 9032 | 0.100 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2417 | 0.100 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1039 | 0.100 |
Why?
|
Cell Lineage | 1 | 2021 | 2557 | 0.100 |
Why?
|
Heart Conduction System | 1 | 2017 | 1007 | 0.100 |
Why?
|
Epigenomics | 2 | 2015 | 943 | 0.100 |
Why?
|
Liposarcoma | 1 | 2014 | 289 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2021 | 3549 | 0.090 |
Why?
|
Disease Progression | 2 | 2020 | 13510 | 0.090 |
Why?
|
Bone Marrow | 1 | 2021 | 2911 | 0.090 |
Why?
|
Monocytes | 2 | 2018 | 2570 | 0.080 |
Why?
|
Leukocytosis | 2 | 2021 | 251 | 0.080 |
Why?
|
Mitosis | 1 | 2014 | 1188 | 0.080 |
Why?
|
Doxorubicin | 2 | 2012 | 2224 | 0.080 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2011 | 618 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2017 | 6345 | 0.080 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2015 | 946 | 0.070 |
Why?
|
Lymphokines | 1 | 2011 | 927 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2015 | 3605 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3617 | 0.070 |
Why?
|
Glioblastoma | 1 | 2023 | 3483 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2017 | 2865 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18255 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4317 | 0.070 |
Why?
|
Organ Specificity | 2 | 2024 | 1968 | 0.070 |
Why?
|
Mice, SCID | 3 | 2018 | 2626 | 0.070 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 727 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1728 | 0.060 |
Why?
|
Liver Regeneration | 1 | 2007 | 213 | 0.060 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2557 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4725 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1964 | 0.060 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 16990 | 0.060 |
Why?
|
Heart | 1 | 2018 | 4404 | 0.060 |
Why?
|
Cohort Studies | 2 | 2020 | 41495 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5127 | 0.060 |
Why?
|
Aging | 2 | 2021 | 8710 | 0.060 |
Why?
|
Heart Atria | 2 | 2023 | 1345 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 4937 | 0.050 |
Why?
|
Female | 17 | 2024 | 392705 | 0.050 |
Why?
|
gamma Catenin | 1 | 2023 | 44 | 0.050 |
Why?
|
RNA, Small Interfering | 3 | 2018 | 3430 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 1827 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.050 |
Why?
|
Mice, Nude | 3 | 2015 | 3614 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11120 | 0.050 |
Why?
|
Versicans | 1 | 2021 | 40 | 0.050 |
Why?
|
Myocardial Infarction | 3 | 2021 | 11461 | 0.050 |
Why?
|
Cholinergic Agents | 1 | 2022 | 96 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6484 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2827 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 265 | 0.050 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 13642 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58984 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5799 | 0.040 |
Why?
|
Lymphatic System | 1 | 2021 | 254 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10774 | 0.040 |
Why?
|
Prognosis | 2 | 2017 | 29629 | 0.040 |
Why?
|
Receptors, Notch | 1 | 2024 | 744 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2021 | 14417 | 0.040 |
Why?
|
Muscle Cells | 1 | 2019 | 195 | 0.040 |
Why?
|
RNA Interference | 2 | 2018 | 2832 | 0.040 |
Why?
|
Edema | 1 | 2023 | 766 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 17904 | 0.040 |
Why?
|
Stem Cell Niche | 1 | 2022 | 345 | 0.040 |
Why?
|
Translocation, Genetic | 1 | 2024 | 1393 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2019 | 350 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4580 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2018 | 178 | 0.040 |
Why?
|
Cell Movement | 2 | 2023 | 5205 | 0.040 |
Why?
|
Aged | 4 | 2024 | 169310 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2020 | 702 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2019 | 412 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 732 | 0.040 |
Why?
|
DNA Methylation | 1 | 2011 | 4399 | 0.040 |
Why?
|
Blotting, Western | 2 | 2015 | 5035 | 0.030 |
Why?
|
Keratins | 1 | 2018 | 498 | 0.030 |
Why?
|
Connexin 43 | 1 | 2017 | 200 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2024 | 1858 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1626 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2017 | 223 | 0.030 |
Why?
|
Gene Deletion | 1 | 2023 | 2665 | 0.030 |
Why?
|
Cell Count | 1 | 2019 | 1835 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12690 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12130 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2024 | 1886 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15936 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1059 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2020 | 0.030 |
Why?
|
Chromosomes | 1 | 2018 | 578 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2018 | 815 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 42232 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2496 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 718 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 2017 | 574 | 0.030 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 2226 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 750 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15502 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2020 | 1119 | 0.030 |
Why?
|
Mitral Valve Insufficiency | 1 | 2023 | 1400 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2017 | 964 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2022 | 18966 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 384 | 0.030 |
Why?
|
Adult | 3 | 2018 | 221210 | 0.030 |
Why?
|
Fatty Acids | 1 | 2021 | 1808 | 0.030 |
Why?
|
Apoptosis | 3 | 2015 | 9490 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 750 | 0.030 |
Why?
|
Middle Aged | 5 | 2024 | 220921 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1175 | 0.030 |
Why?
|
Oncogenes | 1 | 2018 | 1222 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2015 | 2561 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 1749 | 0.020 |
Why?
|
Polymers | 1 | 2019 | 1616 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2024 | 3677 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11904 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3208 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11742 | 0.020 |
Why?
|
Leukocytes | 1 | 2019 | 2026 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 733 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 302 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5305 | 0.020 |
Why?
|
Male | 8 | 2024 | 360846 | 0.020 |
Why?
|
Liver | 1 | 2007 | 7528 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1745 | 0.020 |
Why?
|
Ischemia | 1 | 2019 | 1884 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2418 | 0.020 |
Why?
|
Hypertension | 2 | 2021 | 8540 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2018 | 4615 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1732 | 0.020 |
Why?
|
Collagen Type I | 1 | 2012 | 616 | 0.020 |
Why?
|
Child | 1 | 2017 | 80158 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2017 | 1993 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1351 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 678 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2112 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4758 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2264 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2017 | 1668 | 0.020 |
Why?
|
Pneumonia | 1 | 2019 | 2143 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1898 | 0.020 |
Why?
|
Signal Transduction | 3 | 2020 | 23447 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2019 | 3313 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4853 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4142 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3575 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1062 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6815 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12990 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2467 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3323 | 0.020 |
Why?
|
CpG Islands | 1 | 2011 | 1230 | 0.020 |
Why?
|
Sleep | 1 | 2022 | 4768 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1892 | 0.020 |
Why?
|
Chromosomes, Mammalian | 1 | 2007 | 147 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2898 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6241 | 0.020 |
Why?
|
Benzamides | 1 | 2011 | 1371 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2015 | 2986 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2805 | 0.010 |
Why?
|
Stroke Volume | 1 | 2018 | 5496 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2645 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9647 | 0.010 |
Why?
|
Exercise | 1 | 2019 | 5890 | 0.010 |
Why?
|
Antibodies, Neutralizing | 1 | 2012 | 1943 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4878 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5821 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12794 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7581 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5672 | 0.010 |
Why?
|
Piperazines | 1 | 2011 | 2523 | 0.010 |
Why?
|
Pyrimidines | 1 | 2011 | 3028 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16592 | 0.010 |
Why?
|
Heart Failure | 1 | 2018 | 11671 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7593 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2012 | 64685 | 0.000 |
Why?
|
Concepts
(238)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(110)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_